Why Molnupiravir Fails in Hospitalized Patients
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has radically altered daily life. Effective antiviral therapies to combat COVID-19, especially severe disease, remain scarce. Molnupiravir is an antiviral that has shown...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-12-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.02916-22 |